Non-invasive testing in metabolic dysfunction-associated steatotic liver disease
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously referred to as non-alcoholic fatty liver disease (NAFLD), is a leading cause of chronic liver disease, affecting up to 30% of the global population. MASLD is strongly associated with metabolic risk factors such as obesity a...
| 發表在: | Frontiers in Medicine |
|---|---|
| Main Authors: | , |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
Frontiers Media S.A.
2024-11-01
|
| 主題: | |
| 在線閱讀: | https://www.frontiersin.org/articles/10.3389/fmed.2024.1499013/full |